Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)

Chemical Communications(2022)10.1039/d2cc03092fSource: DataRank Database

Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs) is a research paper published in Chemical Communications (2022). On theSindex it has a DataRank of 0. It has been cited 52 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access52 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: hybridTopics (6)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Cyrille S. Kounde ORCID,Milon Mondal ORCID,Jake L. Greenfield ORCID,Jennifer R. Baker ORCID,Sergei Kotelnikov ORCID

Live enrichment

PubMed:36065962 PMC:PMC9521323

Cancer Research UK

Grant: C24523/A25192

Engineering and Physical Sciences Research Council

Grant: EP/R00188X/1

National Institutes of Health

Grant: R01 GM140098

Engineering and Physical Sciences Research Council

Grant: EP/R512540/1

National Science Foundation

Grant: DMS 2054251

National Institutes of Health

Grant: RM1135136R01

Engineering and Physical Sciences Research Council

Grant: 2100261

Marie Sklodowska-Curie Actions

Grant: H2020

Leverhulme Trust

Grant: RPG-2018-051

GlaxoSmithKline

National Health and Medical Research Council

hybridLicense: cc-by

publisherhttps://pubs.rsc.org/en/content/articlepdf/2022/cc/d2cc03092f

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9521323

repositoryhttps://qmro.qmul.ac.uk/xmlui/handle/123456789/92791

repositoryhttp://hdl.handle.net/10044/1/99433

Europe_PMChttps://europepmc.org/articles/PMC9521323

MeSH Terms

PyrazolesUbiquitin-Protein LigasesProtein KinasesProtein Kinase InhibitorsLightProteolysis